CA2506356A1 - Procedes de therapie et de diagnostic - Google Patents
Procedes de therapie et de diagnostic Download PDFInfo
- Publication number
- CA2506356A1 CA2506356A1 CA002506356A CA2506356A CA2506356A1 CA 2506356 A1 CA2506356 A1 CA 2506356A1 CA 002506356 A CA002506356 A CA 002506356A CA 2506356 A CA2506356 A CA 2506356A CA 2506356 A1 CA2506356 A1 CA 2506356A1
- Authority
- CA
- Canada
- Prior art keywords
- leukemia
- tlr10
- acute
- cell
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
L'invention concerne une thérapie de ciblage utilisant des polypeptides TLR10, des acides nucléiques codant pour des polypeptides TLR10, des anticorps anti-TLR10, qui fournit un procédé qui élimine ou qui inhibe la croissance de cellules cancéreuses exprimant la protéine TLR10. L'invention concerne des procédés de thérapie et de diagnostic de troubles liés aux cellules exprimant la protéine TLR10.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/302,444 US20040022786A1 (en) | 2000-01-21 | 2002-11-22 | Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins |
US10/302,444 | 2002-11-22 | ||
US10/327,491 US20040023870A1 (en) | 2000-01-21 | 2002-12-19 | Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins |
US10/327,491 | 2002-12-19 | ||
US64122203A | 2003-08-13 | 2003-08-13 | |
US10/641,222 | 2003-08-13 | ||
PCT/US2003/036971 WO2004047612A2 (fr) | 2002-11-22 | 2003-11-19 | Procédés de thérapie et de diagnostic |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2506356A1 true CA2506356A1 (fr) | 2004-06-10 |
Family
ID=32397926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002506356A Abandoned CA2506356A1 (fr) | 2002-11-22 | 2003-11-19 | Procedes de therapie et de diagnostic |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1567863A4 (fr) |
AU (1) | AU2003295649A1 (fr) |
CA (1) | CA2506356A1 (fr) |
WO (1) | WO2004047612A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2394596C2 (ru) | 2004-07-09 | 2010-07-20 | Байер Шеринг Фарма Акциенгезельшафт | Комбинированная терапия радиоактивно меченым антителом анти-cd20 при лечении в-клеточной лимфомы |
AU2005269733B2 (en) * | 2004-07-20 | 2008-10-30 | Schering Corporation | Induction of apoptosis in Toll-like receptor expressing tumor cells |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69838888T2 (de) * | 1997-10-17 | 2008-12-11 | Genentech, Inc., South San Francisco | Menschliche Toll-Homologe |
-
2003
- 2003-11-19 EP EP03786850A patent/EP1567863A4/fr not_active Withdrawn
- 2003-11-19 CA CA002506356A patent/CA2506356A1/fr not_active Abandoned
- 2003-11-19 AU AU2003295649A patent/AU2003295649A1/en not_active Abandoned
- 2003-11-19 WO PCT/US2003/036971 patent/WO2004047612A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003295649A1 (en) | 2004-06-18 |
WO2004047612A3 (fr) | 2005-04-14 |
EP1567863A4 (fr) | 2007-10-03 |
WO2004047612A2 (fr) | 2004-06-10 |
EP1567863A2 (fr) | 2005-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040023870A1 (en) | Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins | |
US20050281813A1 (en) | Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins | |
US7378253B2 (en) | Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells | |
US20030215453A1 (en) | Methods of therapy and diagnosis using immunotargeting of cells expressing VpreB1 protein | |
WO2005079490A2 (fr) | Procedes de therapie et de diagnostic reposant sur le ciblage de cellules qui expriment les polypeptides steap2 | |
US20090081209A1 (en) | Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins | |
US20090220416A1 (en) | Immunoglobulin associated cell-surface determinants in the treatment of b-cell disorders | |
US20050095237A1 (en) | Methods of therapy and diagnosis using targeting of cells that express P2Y10 | |
AU2003302733A1 (en) | Methods of therapy and diagnosis using targeting of cells that express LAX | |
WO2004049917A2 (fr) | Procedes de therapie et de diagnostic utilisant le ciblage de cellules d'expression de ly-9 | |
CA2506356A1 (fr) | Procedes de therapie et de diagnostic | |
CA2476555A1 (fr) | Methodes therapeutiques et diagnostiques | |
AU2003213064B2 (en) | Methods of therapy and diagnosis | |
US20050129697A1 (en) | Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides | |
US20040022786A1 (en) | Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins | |
WO2004094607A2 (fr) | Methodes de therapie et de diagnostic utilisant le ciblage de cellules qui expriment une proteine du type transporteur humaine | |
AU2007234602A1 (en) | Methods of therapy and diagnosis | |
US20040109862A1 (en) | Methods of therapy and diagnosis using targeting of cells that express Ly-9 | |
JP2007512836A (ja) | キラー細胞免疫グロブリン様レセプター様タンパク質を発現する細胞の標的化を用いる治療および診断の方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |